GENE - CHEMICAL INTERACTIONS REPORT
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
Object Symbol | Qualifier | Evidence | With | Reference | Source | Notes | Original Reference(s) | Cyp17a1 | decreases expression | EXP | | 6480464 | CTD | Letrozole results in decreased expression of CYP17A1 mRNA | PMID:37254606 | Cyp17a1 | increases expression | EXP | | 6480464 | CTD | Letrozole results in increased expression of CYP17A1 mRNA | PMID:37030623 | Cyp17a1 | multiple interactions | EXP | | 6480464 | CTD | [Letrozole co-treated with tris(2,3-dibromopropyl)isocyanurate] results in decreased expression of CYP17A1 mRNA; diacerein inhibits the reaction [Letrozole results in increased expression of CYP17A1 mRNA] | PMID:37030623 PMID:37254606 | Cyp17a1 | increases expression | ISO | Cyp17a1 (Rattus norvegicus) | 6480464 | CTD | Letrozole results in increased expression of CYP17A1 mRNA | PMID:32298659 | Cyp17a1 | multiple interactions | ISO | Cyp17a1 (Rattus norvegicus) | 6480464 | CTD | Metformin inhibits the reaction [Letrozole results in increased expression of CYP17A1 mRNA]; N(1)-methylnicotinamide inhibits the reaction [Letrozole results in increased expression of CYP17A1 mRNA]; Niacinamide inhibits the reaction [Letrozole results in increased expression of CYP17A1 mRNA] | PMID:32298659 | |
Go Back to source page | Continue to Ontology report |